Connetics Corporation Announces Results Of Special Stockholders Meeting

PALO ALTO, Calif.--(BUSINESS WIRE)--Connetics Corporation (Nasdaq:CNCT), a specialty pharmaceutical company that develops and commercializes dermatology products, today announced that the Company's stockholders approved its merger with Stiefel Laboratories, Inc. at the Special Meeting of Shareholders held on December 20, 2006.
MORE ON THIS TOPIC